DO-BO

What does the future hold for AI in Healthcare, Aleksey Zavgorodniy?

What will the future of AI in healthcare look like? Join us in the latest episode of MAP, the Market Access Podcast, featuring Alexey Zavgorodniy from Unicsoft, and explore the transformative world of artificial intelligence. With extensive experience in AI and large language models, Alexey shares invaluable insights into how AI is reshaping healthcare, pharmaceuticals, and beyond.

In this episode you will learn how AI mirrors the industrial revolution and how that results in both unique opportunities and challenges. Aleksey also illustrates some real-world applications of AI in market access, from predictive analytics in drug pricing to automated literature reviews and more. 

The discussion also goes further into the importance of privacy and ethical considerations that follows AI use, and why it is necessary to ensure data security while maximizing the benefits of technology

Whether you’re an industry professional or a tech enthusiast, this episode offers a comprehensive overview of AI’s current applications and its potential to drive future innovations in healthcare.

Related

In this episode of the Market Access Podcast, Dr. Stefan Walzer sits down with strategy consultant and XR advocate Günther Illert to explore how virtual, augmented, and extended reality are reshaping healthcare—from patient training and pain therapy to surgical planning and medtech education. Learn how cross-sector collaboration and early adoption—especially outside traditional reimbursement systems—can unlock […]

Tune in to this new episode of MAP to explore New Zealand’s unique healthcare and reimbursement landscape with Dr. Stefan Walzer and health economist Dr. Julius Ohnberger. Learn how PHARMAC combines HTA and payer roles, why equity and Māori health outcomes are central to market access and what global pharma can gain from launching in […]

In this brand new episode of MAP – the Market Access Podcast, Dr. Stefan Walzer sits down with Elizabeth Shanahan, AI Strategy Lead at Sanofi, for a refreshingly honest conversation on the real-world implementation of artificial intelligence in pricing, evidence generation, and HTA processes. From streamlining evidence generation to enhancing pricing strategies and dossier creation, […]